← Back to Clinical Trials
Recruiting NCT06279988

NCT06279988 BRING-UP 3 Heart Failure

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06279988
Status Recruiting
Phase
Sponsor Heart Care Foundation
Condition Heart Failure
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2023-09-15
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10,000 participants in total. It began in 2023-09-15 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this observational study is to assess the level of adherence to guideline recommendations regarding the management of patients with Heart Failure with Reduced Ejection Fraction (HFrEF); - the safety profile of the implementation of recommended treatments; - to monitor treatment patterns of patients with acute hert failure (HF); - to monitor treatment patterns of all patients with chronic HF irrespective of the level of ejection fraction (EF).

Eligibility Criteria

Inclusion Criteria: 1. Age ≥18 years old. 2. Males and females at birth. 3. Any ejection fraction level (level of ejection fraction measured in the 6 months preceding enrollment). 4. Ambulatory chronic HF or Hospitalized de-novo or worsening HF. 5. Signed informed consent Diagnosis will be made by the local attending physician following the ESC guidelines recommendations. Exclusion Criteria: 1. Active neoplasia or very severe disease compromising short-medium term life expectancy. 2. Participation in interventional studies. 3. Patients already enrolled into the study from another participating center or in the previous enrolling phase.

Contact & Investigator

Central Contact

Fabrizio G Oliva, MD

✉ bringup3.scompenso@heartcarefoundation.it

📞 055/5101361

Frequently Asked Questions

Who can join the NCT06279988 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06279988 currently recruiting?

Yes, NCT06279988 is actively recruiting participants. Contact the research team at bringup3.scompenso@heartcarefoundation.it for enrollment information.

Where is the NCT06279988 trial being conducted?

This trial is being conducted at Casale Monferrato, Italy, Novi Ligure, Italy, Ancona, Italy, Ancona, Italy and 11 additional locations.

Who is sponsoring the NCT06279988 clinical trial?

NCT06279988 is sponsored by Heart Care Foundation. The trial plans to enroll 10,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology